Senestech Inc
senestech.comWhat Do They Do?
Develops and sells fertility-control baits for rat and mouse population management to pest-management professionals, agricultural businesses and other end users.
10-K for FY2025, filed Mar 13, 2026We have developed and are commercializing products for managing animal pest populations through fertility control and population management…View ↗
EVOLVE. The Evolve product line launched in January 2024 as Evolve Rat and is currently our primary revenue-generating product. Evolve Rat…View ↗
In May 2024, we introduced Evolve Mouse, expanding the Evolve product line to address additional rodent species. Evolve Mouse is a modified…View ↗
Because the pest industry in the United States has demonstrated a reluctance to adopt new technologies, the marketing of fertility control…View ↗
How Do They Make Money?
Customers buy products at fixed prices, with payment due after shipment; the company also earns fees for pilot studies, consulting and implementation services performed under service contracts.
10-K for FY2025, filed Mar 13, 2026
$2.2M
-
10-K for FY2025, filed Mar 13, 2026
$2.2M ↗
Who Are Their Customers?
The company sells through e-commerce, pest-management professionals and retail channels. It markets Evolve products internationally through distributors.
10-K for FY2025, filed Mar 13, 2026We have also begun to market Evolve products internationally through distributors.View ↗
Because the pest industry in the United States has demonstrated a reluctance to adopt new technologies, the marketing of fertility control…View ↗
During 2025, we experienced strong growth in our Evolve product line, which now represents the majority of our total revenue. Sales of…View ↗
Do Revenues Turn Into Profits?
No. It lost $6.4M in FY2025.
10-K for FY2025, filed Mar 13, 2026
−$6.5MView ↗
10-K for FY2025, filed Mar 13, 2026
−$6.4MView ↗
10-K for FY2025, filed Mar 13, 2026
−$5.9MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 6, 2026
−$1.8MView ↗
- ▲ +13% (Loss)
- vs −$1.6M in Q2 FY2025
-
May 7, 2026
Michael Edell became CEO, succeeding Joel Fruendt
Jamie Bechtel's role as Interim Executive Chair concluded.
Sources
8-K, filed May 7, 2026
On May 6, 2026 (the “Commencement Date”), the Board of Directors (the “Board”) of SenesTech, Inc. (the “Company”) appointed Michael Edell…View ↗
Growing. Revenue grew 3.7x in 4 years, from $600K in FY2021 to $2.2M in FY2025, about 39% a year.
Broader product range
The earlier report centered on ContraPest for rats; the latest describes Evolve Rat and Evolve Mouse alongside ContraPest.
10-K for FY2022, filed Mar 17, 2023 10-K for FY2025, filed Mar 13, 2026ContraPest®, our initial product, is novel liquid bait in the pest control industry. ContraPest targets the reproductive systems of both…View ↗
We have developed and are commercializing products for managing animal pest populations through fertility control and population management…View ↗
EVOLVE. The Evolve product line launched in January 2024 as Evolve Rat and is currently our primary revenue-generating product. Evolve Rat…View ↗
In May 2024, we introduced Evolve Mouse, expanding the Evolve product line to address additional rodent species. Evolve Mouse is a modified…View ↗
International distribution
The earlier report described evaluating requests and possible partners for international ContraPest sales; the latest says Evolve products are being marketed internationally through distributors.
10-K for FY2022, filed Mar 17, 2023 10-K for FY2025, filed Mar 13, 2026Our current focus is successful commercialization of ContraPest in the United States. Aware of the global need for effective rat fertility…View ↗
We have also begun to market Evolve products internationally through distributors.View ↗
Loading...
